Quibim vs Veye Lung Nodules
AI-enhanced independent comparison — features, pros, cons, pricing and rankings.
| Dimension | Quibim | Veye Lung Nodules |
|---|---|---|
| Accuracy & Reliability | — | |
| Ease of Use | — | |
| Features & Capability | — | |
| Value for Money | — | |
| Performance & Speed | — | |
| Popularity & Adoption | — |
Who each tool serves best — and when to pick the other one.
Radiologists, medical imaging researchers, and healthcare providers seeking quantitative biomarker analysis from diagnostic images.
- You need precise quantitative analysis of medical imaging biomarkers for diagnostics.
- You want to enhance clinical decision-making with objective imaging data.
- Your team requires specialized imaging AI focused on biomarker extraction.
Organizations needing extensive third-party integrations or open API access for custom workflows should consider other options.
- You need extensive API access for custom integration and automation workflows.
- Free-tier limits are a blocker for your clinical research volume or scale.
- You require broad third-party software integrations beyond imaging platforms.
The ability to extract validated quantitative imaging biomarkers for clinical and research use.
Radiologists and clinical teams needing precise lung nodule detection integrated into existing imaging workflows.
- You need to improve lung nodule detection accuracy in chest CT scans
- You want to streamline radiology workflows with AI-assisted diagnostics
- Your team requires FDA-cleared software for clinical imaging support
Clinics without CT imaging capabilities or those requiring fully open-source solutions should avoid this tool.
- You need AI tools for non-imaging medical diagnostics
- Free-tier limits are a blocker for your clinical volume needs
- You require fully open-source or self-hosted AI solutions
Accuracy and clinical integration for lung nodule detection in CT imaging.
A canonical comparison across capabilities common to this category. Vendor-specific extras appear below in "Highlighted Features".
| Capability | Quibim | Veye Lung Nodules |
|---|---|---|
|
Free Tier Available
Usable without payment (with usage limits)
|
✓ | ✓ |
Each tool's marketing-listed features. Where a feature appears under one tool but not the other, it usually reflects how the vendor describes their product — not a definitive capability gap.
- Quantitative Biomarker Extraction — Extracts validated imaging biomarkers from medical images
- Multi-model Support — Supports MRI, CT, and other imaging modalities
- Cloud-Based Platform — Accessible via web without local installation
- Advanced Imaging Analytics — Provides detailed quantitative analysis tools
- Research Collaboration Tools — Supports collaborative workflows for clinical research
- Lung Nodule Detection — Automated identification of lung nodules in CT scans
- Clinical workflow integration — Seamless integration with radiology PACS systems
- FDA Clearance — Regulatory approval for clinical diagnostic use
- Cloud deployment — Accessible via secure cloud platform
- Volume-based Pricing — Pricing scales with scan volume and usage
- Specialized in quantitative imaging biomarkers
- Clinically validated algorithms
- Cloud-based platform for easy access
- Supports multiple imaging modalities
- Focus on reproducibility and objectivity
- Accurate lung nodule detection validated clinically
- FDA-cleared for diagnostic use
- Improves radiologist workflow efficiency
- Cloud-based deployment for easy access
- Supports early lung cancer screening
- Limited public pricing information
- No publicly available API for integration
- Lack of mobile app limits on-the-go access
- Pricing details are not fully transparent
- No open-source or on-premise deployment option
- Limited public information on trial availability
- Radiology diagnostic support
- Clinical research biomarker quantification
- Oncology imaging analysis
- Neurology imaging biomarker extraction
- Pharmaceutical imaging trials
- Lung cancer screening programs
- Radiology diagnostic support
- Clinical decision support for pulmonologists
- Medical imaging workflow optimization
- Research on lung nodule detection
Natural languages each tool generates and understands. Primary languages are listed first.
What each tool can accept (input) and produce (output) — text, image, audio, video, code.
Offers a freemium model with limited free features; paid tiers provide advanced imaging analysis capabilities. Exact pricing details are not publicly disclosed.
-
Free
Free
Offers a free tier with basic features and paid plans for advanced clinical use; detailed pricing requires contact.
-
Free
Free
Regulatory frameworks each tool claims compliance with (HIPAA, SOC 2, GDPR, etc.).
Third-party audits and certifications that verify security controls.
No certifications listed.
Vendor-published numbers each tool highlights — usage scale, breadth, and operational stats. Different tools track different metrics, so direct row-by-row comparison usually isn't meaningful.
- Imaging Biomarkers Extracted Thousands
- Detection Accuracy High
- Workflow Efficiency Improved
Who each tool is positioned for — primary audience first.
How you can reach support — email, live chat, phone, community, docs.
- Email primary
- Email primary
How each tool is classified in the Volvenix catalog.
These vocabulary domains are managed in our catalog but not yet exposed at the tool level. We're tracking them for future expansion of this comparison.
- Encryption Types — AES-256, ChaCha20, RSA-2048, and similar at-rest/in-transit cipher families.
- Encryption Contexts — where encryption is applied (data at rest, in transit, end-to-end).
- Plan-tier Model Mapping — which AI models are available on which pricing tier (currently only the model list is tracked, not the per-plan availability).
- What is this tool?
- Quibim is a cloud-based platform that extracts quantitative imaging biomarkers from medical images to support clinical decision-making.
- How much does it cost?
- Quibim offers a freemium pricing model with a free tier; detailed paid pricing is not publicly disclosed.
- Does it have a free plan?
- Yes, Quibim provides a free plan with limited access to core imaging biomarker extraction features.
- What integrations does it support?
- Quibim currently does not publicly document integrations or API access.
- Who is it best for?
- It is best suited for radiologists, medical researchers, and healthcare providers needing quantitative imaging biomarker analysis.
- What is this tool?
- Veye Lung Nodules is an AI software that detects lung nodules in CT scans to assist radiologists.
- How much does it cost?
- It offers a free tier with basic features; detailed pricing for clinical use requires contacting the vendor.
- Does it have a free plan?
- Yes, a free plan with limited features is available for individual users.
- What integrations does it support?
- It integrates with clinical PACS systems to fit into radiology workflows.
- Who is it best for?
- Radiologists and clinical teams needing precise lung nodule detection in CT imaging.
| Info | Quibim | Veye Lung Nodules |
|---|---|---|
| Pricing | Freemium | Freemium |
| Category | Healthcare & Medical AI | Healthcare & Medical AI |
| Deployment | Cloud | Cloud |
| Learning Curve | Intermediate | Intermediate |
| Free Plan | ✓ | ✓ |
| AI Agent | ✗ | ✗ |
| Autonomy | Assistant | Assistant |
| Risk Tier | Medium | Medium |
Veye Lung Nodules and Quibim both have an overall score of 5.5/10 and offer freemium pricing models. Veye Lung Nodules focuses specifically on lung nodule detection and analysis, catering primarily to radiologists and pulmonologists, while Quibim provides a broader range of imaging biomarker analysis across multiple modalities and clinical applications. Pricing for both includes free access with limited features, but detailed pricing tiers and feature sets may vary based on the specific use cases and volume of data processed.
ⓘ How Volvenix scores work
Scores are computed by Volvenix — not supplied by the vendors, and not third-party benchmark results. Each 0–10 dimension (Overall, Features, Usability, Support, Pricing) is a directional estimate aggregated from catalog signals — editorial cataloguing, content depth, engagement, and provider-reputation indicators — so treat them as a starting point, not a lab result.
Confidence reflects how complete the underlying data is for both tools; lower confidence means fewer signals were available, not a worse tool. We never accept payment for rankings or scores. More about how Volvenix works →